Home › Immunoblastic Lymphadenopathy › Michigan › Ann Arbor
Immunoblastic Lymphadenopathy clinical trials in Ann Arbor, MI
3 studies for Immunoblastic Lymphadenopathy are looking for participants at sites in and around Ann Arbor (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
RecruitingPhase 2
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · 18 mi away
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
RecruitingPhase 3
- Roger Cancer Center University of Michigan Health, Ann Arbor
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
RecruitingPhase 1
- University of Michigan, Ann Arbor
Immunoblastic Lymphadenopathy trials in other cities
- New York City, NY5 studies
- Chicago, IL4 studies
- Houston, TX4 studies
- Durham, NC4 studies
- Miami, FL4 studies
- Baldwin Park, CA3 studies
- St. Louis, MO3 studies
- Boston, MA3 studies
- New Haven, CT3 studies
- Columbus, OH3 studies
- Atlanta, GA3 studies
- Rochester, MN3 studies
Other studies in Ann Arbor
- Prostate Cancer27 studies
- Breast Cancer26 studies
- Non-Small Cell Lung Cancer26 studies
- Cancer (all types)25 studies
- Colorectal Cancer23 studies
- Lung Cancer23 studies
- Heart Failure22 studies
- Acute Myeloid Leukemia17 studies
- Cardiovascular Disease16 studies
- Pancreatic Cancer14 studies
- Melanoma12 studies
- Kidney Cancer (Renal Cell Carcinoma)12 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.